Table 6 GSVA enrichment summary

GSE55235

KEGG_PRIMARY_IMMUNODEFICIENCY

0.723

0.004

 < 0.001

 < 0.001

KEGG_ALLOGRAFT_REJECTION

0.702

0.016

 < 0.001

 < 0.001

KEGG_VIRAL_MYOCARDITIS

0.492

0.011

 < 0.001

 < 0.001

KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS

0.469

0.007

 < 0.001

 < 0.001

KEGG_LEISHMANIA_INFECTION

0.479

-0.001

 < 0.001

 < 0.001

KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION

0.564

0.008

 < 0.001

 < 0.001

KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION

0.508

-0.004

 < 0.001

 < 0.001

KEGG_GRAFT_VERSUS_HOST_DISEASE

0.633

0.03

 < 0.001

 < 0.001

KEGG_TYPE_I_DIABETES_MELLITUS

0.528

0.014

 < 0.001

 < 0.001

KEGG_ASTHMA

0.549

0.032

 < 0.001

 < 0.001

KEGG_CELL_ADHESION_MOLECULES_CAMS

0.436

0.021

 < 0.001

 < 0.001

KEGG_LYSOSOME

0.488

0.029

 < 0.001

 < 0.001

KEGG_CHEMOKINE_SIGNALING_PATHWAY

0.322

0.014

 < 0.001

 < 0.001

KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION

0.352

0.003

 < 0.001

 < 0.001

KEGG_AUTOIMMUNE_THYROID_DISEASE

0.512

0.007

 < 0.001

 < 0.001

KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS

0.345

0.009

 < 0.001

 < 0.001

KEGG_HEMATOPOIETIC_CELL_LINEAGE

0.318

0.012

 < 0.001

 < 0.001

KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY

0.328

0.008

 < 0.001

0.001

KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES

0.419

0.004

 < 0.001

0.001

KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY

0.346

0.003

 < 0.001

0.001

KEGG_N_GLYCAN_BIOSYNTHESIS

0.384

0.012

 < 0.001

0.002

KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM

0.343

0.028

 < 0.001

0.002

KEGG_FOLATE_BIOSYNTHESIS

0.418

0.006

 < 0.001

0.003

KEGG_VIBRIO_CHOLERAE_INFECTION

0.343

0.006

 < 0.001

0.004

KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES

0.443

0.017

 < 0.001

0.004

KEGG_SULFUR_METABOLISM

0.461

0.027

 < 0.001

0.005

KEGG_OTHER_GLYCAN_DEGRADATION

0.45

0.022

0.003

0.017

KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT

0.29

0.014

0.003

0.017

KEGG_ETHER_LIPID_METABOLISM

0.276

-0.009

0.004

0.02

KEGG_GLYCOSAMINOGLYCAN_DEGRADATION

0.307

0.018

0.004

0.02

KEGG_OXIDATIVE_PHOSPHORYLATION

0.338

-0.003

0.006

0.027

KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES

0.272

0

0.007

0.03

KEGG_TGF_BETA_SIGNALING_PATHWAY

-0.352

-0.012

 < 0.001

 < 0.001

KEGG_SPLICEOSOME

-0.43

-0.035

 < 0.001

0.001

KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450

-0.281

-0.015

 < 0.001

0.002

KEGG_CIRCADIAN_RHYTHM_MAMMAL

-0.487

-0.043

 < 0.001

0.003

KEGG_TYROSINE_METABOLISM

-0.264

0.001

 < 0.001

0.005

KEGG_RIBOSOME

-0.365

-0.031

0.008

0.03

KEGG_PHENYLALANINE_METABOLISM

-0.278

0.009

0.009

0.033

GSE55457

KEGG_MISMATCH_REPAIR

0.477

0.006

 < 0.001

0.005

KEGG_CELL_CYCLE

0.325

0.003

 < 0.001

0.005

KEGG_DNA_REPLICATION

0.456

-0.011

 < 0.001

0.015

KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY

0.274

0.023

 < 0.001

0.015

KEGG_TYPE_I_DIABETES_MELLITUS

0.459

0.011

 < 0.001

0.015

KEGG_AMINOACYL_TRNA_BIOSYNTHESIS

0.367

0.011

 < 0.001

0.015

KEGG_AUTOIMMUNE_THYROID_DISEASE

0.427

0.01

 < 0.001

0.015

KEGG_GRAFT_VERSUS_HOST_DISEASE

0.505

0.025

 < 0.001

0.015

KEGG_ALLOGRAFT_REJECTION

0.533

0.018

 < 0.001

0.015

KEGG_PRIMARY_IMMUNODEFICIENCY

0.492

0.002

 < 0.001

0.016

KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY

0.267

0.024

0.002

0.025

KEGG_NUCLEOTIDE_EXCISION_REPAIR

0.295

0.006

0.002

0.025

KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION

0.344

0.017

0.003

0.027

KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY

0.311

0.012

0.003

0.027

KEGG_HEDGEHOG_SIGNALING_PATHWAY

-0.274

-0.014

0.001

0.021